Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Pacific Biosciences of California, Inc. (PACB : NSDQ)
 
 • Company Description   
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.

Number of Employees: 728

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.61 Daily Weekly Monthly
20 Day Moving Average: 7,636,846 shares
Shares Outstanding: 224.38 (millions)
Market Capitalization: $1,258.79 (millions)
Beta: 1.43
52 Week High: $36.36
52 Week Low: $4.51
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -15.89% -5.28%
12 Week -49.00% -43.94%
Year To Date -72.58% -66.56%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1305 O`BRIEN DRIVE
-
MENLO PARK,CA 94025
USA
ph: 650-521-8000
fax: 302-636-5454
ir@pacb.com http://www.pacb.com
 
 • General Corporate Information   
Officers
Christian O. Henry - Chief Executive Officer and President
John F. Milligan - Chairman
Susan G. Kim - Chief Financial Officer
Michele Farmer - Vice President and Chief Accounting Officer
David Botstein - Director

Peer Information
Pacific Biosciences of California, Inc. (ABMD)
Pacific Biosciences of California, Inc. (DMDS)
Pacific Biosciences of California, Inc. (CPWY.)
Pacific Biosciences of California, Inc. (EQUR)
Pacific Biosciences of California, Inc. (ECIA)
Pacific Biosciences of California, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 69404D108
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/02/22
Share - Related Items
Shares Outstanding: 224.38
Most Recent Split Date: (:1)
Beta: 1.43
Market Capitalization: $1,258.79 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.34 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.38 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/02/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.71
Price/Cash Flow: -
Price / Sales: 9.35
EPS Growth
vs. Year Ago Period: -105.56%
vs. Previous Quarter: -23.33%
Sales Growth
vs. Year Ago Period: 14.40%
vs. Previous Quarter: -7.90%
ROE
03/31/22 - -36.11
12/31/21 - -35.02
09/30/21 - -29.42
ROA
03/31/22 - -13.12
12/31/21 - -11.62
09/30/21 - -10.20
Current Ratio
03/31/22 - 16.87
12/31/21 - 15.36
09/30/21 - 20.32
Quick Ratio
03/31/22 - 16.38
12/31/21 - 15.01
09/30/21 - 19.99
Operating Margin
03/31/22 - -175.91
12/31/21 - -145.61
09/30/21 - -103.71
Net Margin
03/31/22 - -130.14
12/31/21 - -138.85
09/30/21 - -30.39
Pre-Tax Margin
03/31/22 - -199.67
12/31/21 - -210.61
09/30/21 - -108.35
Book Value
03/31/22 - 3.27
12/31/21 - 3.59
09/30/21 - 4.22
Inventory Turnover
03/31/22 - 3.30
12/31/21 - 3.72
09/30/21 - 4.08
Debt-to-Equity
03/31/22 - 1.22
12/31/21 - 1.13
09/30/21 - 1.07
Debt-to-Capital
03/31/22 - 54.96
12/31/21 - 53.11
09/30/21 - 51.59
 

Powered by Zacks Investment Research ©